Dubai, United Arab Emirates Advanced Watertek celebrates its 40th anniversary of providing bespoke membrane-based water and wastewater treatment systems. The company has successfully manufactured, commissioned, and installed thousands of systems in over 50 countries. Since establishment, it has maintained the industry’s highest quality standards. Founded in Perth, Australia in 1984,Continue Reading

Gradiant’s H+E Wins Contract in Germany to Build Water Treatment Facility for One of the Largest Semiconductor Fabs

The contract award follows the European Chips Act’s passing in September to bolster competitiveness and resilience in semiconductors BOSTON Gradiant, a global solutions provider for advanced water and wastewater treatment, today announced that its recently acquired subsidiary, H+E Group, has been awarded a new contract to design and build anContinue Reading

IASO Bio Establishes International CAR-T Diagnostic and Treatment Center in China to Serve MM Patients Worldwide

NANJING, China — Nanjing IASO Biotechnology Co., Ltd. (IASO Bio) made its debut at the 6th China International Import Expo (CIIE) with FUCASO, the world’s first fully-human CAR-T, and entered into a strategic partnership with several international medical institutions, bringing hope for cure to multiple myeloma (MM) patients worldwide. On JuneContinue Reading

Ketamine Clinic in Japan for Inbound Medical Treatment: Nagoya Anesthesia Clinic

NAGOYA, Japan — Nagoya Anesthesia Clinic located in Nagoya City, Aichi Prefecture, Japan, has initiated inbound medical treatment for treatment-resistant depression, other mental disorders, and intractable chronic pain, utilizing the groundbreaking drug Ketamine. Over the past 15 years, the clinic has provided ketamine therapy through more than 1300 ketamine infusions.Continue Reading

BaroPace, Inc. Announced First Patient Enrolled in Non-Pharmacologic Hypertension and Heart Failure Treatment Trial

SAMMAMISH, Wash. — BaroPace Inc., a medical device company focused on the development of PressurePace™, a real-time physiologic control software and hardware to regulate cardiac pacemakers to treat resistant hypertension and heart failure with preserved ejection fraction (HFpEF), today announced that the first patient has been enrolled in the Company’sContinue Reading

Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive licensing and commercialisation agreement with Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercialising precision, cell targeting therapies based on its proprietary Alluminox™ platform. Under the terms of the agreement, Hikma hasContinue Reading